GEM

Tender Notice for Cap Midostaurin 25 mg,Tab Venetoclax 100 mg,Tab Azacitidine 300 mg,Inj Cyclosporine 50 mg,Cyclophos in KOLKATA, WEST BENGAL

Posted

25 Jun 2025, 11:09 am

Deadline

16 Jul 2025, 12:00 pm

EMD

₹20,337

Location

KOLKATA , WEST BENGAL

Progress

RA
Issue25 Jun 2025, 11:09 am
Reverse Auction22 Aug 2025, 02:00 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

10687

Category

Cap Midostaurin 25 mg

Bid Type

Two Packet Bid

Categories 2

ASPARAGINASE ACID

Indian Army invites bids for Cap Midostaurin 25 mg, Tab Venetoclax 100 mg, Tab Azacitidine 300 mg, Inj Cyclosporine 50 mg, Cyclophosphamide 500 mg Inj, Cytosine Arabinoside 500 mg Inj, Cytosine Arabinoside Preservative free 100 mg Inj, Daunorubicin 20 mg Inj, Mercaptopurine 50 mg Tab, Inj Methotrexate 500mg, Mesna 200mg Inj, Tab Ruxolitinib 20 mg, Al trans retinoic Acid 10 mg Cap, Zoledronic Acid 5 mg Inj, Idarubicin 5mg slace ml Inj, Desferrioxamine 500 mg Inj, Lenalidomide 10 mg Cap, 3rd Gen Recombinant Factor VIII Injection 500 IU, Inj Decitabine 50 mg, Inj Brentuximab Vedotin 50 mg, Inj Crizanlizumab 10 mg slace ml 10ml, inj isavuconazole 200 mg, Inj Luspatercept 25 mg, Inj Luspatercept 75 mg, Inj Peg Asparaginase 3750 U, Inj Rasburicase 1 point 5 mg, Inj Romiplostim 250 mcg, Inj Romiplostim 125 mg, Inj Thiotepa 100 mg, Inj Thiotepa 15 mg, Inj Treosulfan 5 gm, Tab Pomalidomide 2 mg, Inj Feiba 500 IU, Tab Posaconazole 100 mg, Polatuzumanb Vedotin 30 mg, Nonacog beta pegol 500 IU Lyophilized powder for solution for Injection Glycopegylated Recombinant Factor IX in KOLKATA, WEST BENGAL. Quantity: 10687. Submission Deadline: 16-07-2025 12: 00: 00. Submit your proposal before the deadline.

Bill of Quantities (BOQ) 36 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Cap Midostaurin 25 mg Cap Midostaurin 25 mg 600 nos consignee2dglp 30
2 Tab Venetoclax 100 mg Tab Venetoclax 100 mg 720 no consignee2dglp 30
3 Tab Azacitidine 300 mg Tab Azacitidine 300 mg 300 nos consignee2dglp 30
4 Inj Cyclosporine 50 mg Inj Cyclosporine 50 mg 300 vial consignee2dglp 30
5 Cyclophosphamide 500 mg Inj Cyclophosphamide 500 mg Inj 72 amp slace vial consignee2dglp 30
6 Cytosine Arabinoside 500 mg Inj Cytosine Arabinoside 500 mg Inj 150 amp slace vial consignee2dglp 30
7 Cytosine Arabinoside Preservative free 100 mg Inj Cytosine Arabinoside (Preservative free) 100 mg Inj 90 amp slace vial consignee2dglp 30
8 Daunorubicin 20 mg Inj Daunorubicin 20 mg Inj 30 amp slace vial consignee2dglp 30
9 Mercaptopurine 50 mg Tab Mercaptopurine 50 mg Tab 1,200 no consignee2dglp 30
10 Inj Methotrexate 500mg Inj Methotrexate 500mg 240 vial consignee2dglp 30
11 Mesna 200mg Inj Mesna 200mg Inj 60 amp slace vial consignee2dglp 30
12 Tab Ruxolitinib 20 mg Tab Ruxolitinib 20 mg 300 no consignee2dglp 30
13 Al trans retinoic Acid 10 mg Cap Al trans retinoic Acid 10 mg Cap 540 no consignee2dglp 30
14 Zoledronic Acid 5 mg Inj Zoledronic Acid 5 mg Inj 30 amp slace vial consignee2dglp 30
15 Idarubicin 5mg slace ml Inj Idarubicin 5mg slace ml Inj 30 vial consignee2dglp 30
16 Desferrioxamine 500 mg Inj Desferrioxamine 500 mg Inj 30 amp slace vial consignee2dglp 30
17 Lenalidomide 10 mg Cap Lenalidomide 10 mg Cap 3,000 no consignee2dglp 30
18 3rd Gen Recombinant Factor VIII Injection 500 IU 3rd Gen Recombinant Factor VIII Injection 500 IU 168 vial consignee2dglp 30
19 Inj Decitabine 50 mg Inj Decitabine 50 mg 90 vial consignee2dglp 30
20 Inj Brentuximab Vedotin 50 mg Inj Brentuximab Vedotin 50 mg 18 vial consignee2dglp 30
21 Inj Crizanlizumab 10 mg slace ml 10ml Inj Crizanlizumab 10 mg slace ml (10ml) 18 vial consignee2dglp 30
22 inj isavuconazole 200 mg inj isavuconazole 200 mg 30 vial consignee2dglp 30
23 Inj Luspatercept 25 mg Inj Luspatercept 25 mg 36 vial consignee2dglp 30
24 Inj Luspatercept 75 mg Inj Luspatercept 75 mg 24 vial consignee2dglp 30
25 Inj Peg Asparaginase 3750 U Inj Peg Asparaginase 3750 U 12 vial consignee2dglp 30
26 Inj Rasburicase 1 point 5 mg Inj Rasburicase 1.5 mg 6 amp consignee2dglp 30
27 Inj Romiplostim 250 mcg Inj Romiplostim 250 mcg 72 vial consignee2dglp 30
28 Inj Romiplostim 125 mg Inj Romiplostim 125 mg 150 vial consignee2dglp 30
29 Inj Thiotepa 100 mg Inj Thiotepa 100 mg 6 amp consignee2dglp 30
30 Inj Thiotepa 15 mg Inj Thiotepa 15 mg 6 vial consignee2dglp 30
31 Inj Treosulfan 5 gm Inj Treosulfan 5 gm 6 vial consignee2dglp 30
32 Tab Pomalidomide 2 mg Tab Pomalidomide 2 mg 1,260 no consignee2dglp 30
33 Inj Feiba 500 IU Inj Feiba 500 IU 12 vial consignee2dglp 30
34 Tab Posaconazole 100 mg Tab Posaconazole 100 mg 1,060 nos consignee2dglp 30
35 Polatuzumanb Vedotin 30 mg Polatuzumanb Vedotin 30 mg 6 vial consignee2dglp 30
36 Nonacog beta pegol 500 IU Lyophilized powder for solution for Injection Glycopegylated Recombinant Factor IX Nonacog beta pegol 500 IU (Lyophilized powder for solution for Injection) Glycopegylated Recombinant Factor IX 15 vial consignee2dglp 30

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Reverse Auction Schedule

Completed

Start

22 Aug 2025, 02:00 pm

End

06 Sept 2025, 11:00 am

Duration: 357 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

What are the eligibility requirements for tender participation?

The eligibility requirements include being a registered entity qualified to supply pharmaceutical products, with valid licenses to operate within the sector. Bidders should also have experience in dealing with government contracts, particularly in providing healthcare solutions.

What are the required certificates to submit?

Selected bidders must provide various essential certificates including quality assurance certifications, product registrations with health authorities, and any other relevant documentation to demonstrate compliance with national healthcare standards.

What is the registration process for participating in the tender?

To participate in the tender, bidders must follow a structured registration process, which includes submitting necessary documents electronically through the portal and registering their entity details to authenticate their ability to fulfill the contract obligations.

What document formats are accepted for submissions?

Submissions should comply with specified document formats which typically include PDF, Word, or Excel. It is crucial to ensure that all documents are clear, legible, and formatted according to the requirements outlined in the tender documents.

What benefits do MSEs receive when participating in this tender?

Micro, Small and Medium Enterprises (MSEs) have specific benefits such as reserved quotas in bidding processes and potential price preferences to encourage local participation. This initiative strengthens local industry while ensuring quality supply to military healthcare needs.